Exercise of Options and Total Voting Rights

RNS Number : 8049S

CVS Group plc

21 March 2016

 

21 March 2016

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, the UK's leading provider of integrated veterinary services, announces that 1,245 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued today as a result of the exercise of employee share options, in connection with the Company's 2012/2015 Save As You Earn Scheme.

The SAYE Shares rank pari passu with all existing Ordinary Shares.  The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 14 December 2015.

Following issue of the SAYE Shares today, the Company's total issued share capital is 59,982,603 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 59,982,603. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

In addition, 1,209 Ordinary Shares (the "New Shares") were allotted on 18 March 2016 as a result of the exercise of employee share options by a former employee, in connection with the Company's 2013/2016 Save As You Earn Scheme. Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or around 29 March 2016.

Following the issue of the New Shares on 29 March 2016, the Company's total issued share capital will be 59,983,812 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company will be 59,983,812. Following the issue of the New Shares on 29 March 2016, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Contacts:

CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director	Tel: [phone]
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Liz Yong	Tel: [phone]

 

END

 

 

MSCBLGDXGSDBGLB